BioView · raw details

Automated Cell Diagnostic Platform · Rehovot · Founded 1998

active Public ← back to profile

Highlights

1 patentProfile claimed by owner

About

Automated Cell Diagnostic Platform

BioView develops, manufactures, and markets automated cell-imaging and analysis solutions for use in cytology, cytogenetic, pathology, clinical, and research laboratories. The company's products include a wide range of FDA-cleared clinical applications as well as web review and analysis solutions.

BioView's proprietary imaging, analysis, and review technology automatically controls fully motorized fluorescent and bright-field microscopes equipped with high-resolution cameras. This automates the review, analysis, and reporting processes and reduces laboratories' turnaround time on labor-intensive tests.

BioView's DUET imaging and analysis platform has received FDA clearance for several FISH applications for cancer detection and diagnosis and detection of genetic aberrations. BioView products have CE marking, as well as a Korean, Australian, and Thai FDA approval. The company is continually expanding its regulatory approval reach to additional countries.

The company is currently developing and plans to market its proprietary, self-developed test for noninvasive early detection of lung cancer, combining a biological test kit and BioView's unique Target FISH application.

Identity

NameBioView
Slugbioview
Type / kindstartup
Crunchbase IDbioview
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7Z49ALDA

Status

Statusactive
Status reasonPublic on TASE on Jul, 2006<br>
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtCenter District
HQ cityRehovot
HQ addressProf. Haim Pekeris Street 3, Rehovot, Israel

Web & social

Websitehttps://bioview.com/
LinkedInhttps://www.linkedin.com/company/80102
Twitter / Xhttps://twitter.com/bio_view
Facebookhttps://www.facebook.com/BioViewInc

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Platforms & InterfacesSoftwareSimulation & Imaging
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesLife SciencesBiotechnology
Business models
B2B
Tags
diagnosticsimagingmedical-technologiesmedical-equipmentcellslaboratoriesmobile-devicescancergeneticsnon-invasiveartificial-intelligenceoncologyurologyhospitalsoptronicshematologyhardwaremedical-devicessaas

Funding

Total raised
Current stagePublic
Market cap$7.2M

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}